LSP Dementia Fund is EQT Life Sciences’ dementia-focused venture fund backing drug development and medical technology for neurodegenerative diseases. It invests through the EQT Life Sciences platform across life sciences, biotechnology, pharmaceuticals, medical devices and healthtech, and backs early-stage companies, including Series A activity in Denmark. The platform’s investment range is €10-60M, making it relevant for therapeutic and medtech companies seeking specialist life sciences capital.